These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23246457)

  • 1. Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD).
    Narayanankutty A; Reséndiz-Hernández JM; Falfán-Valencia R; Teran LM
    Clin Biochem; 2013 May; 46(7-8):566-78. PubMed ID: 23246457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease.
    Choi JH; Kim MA; Park HS
    Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):1-6. PubMed ID: 24300420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiopathology of aspirin intolerant asthma].
    Carsin A; Bienvenu J; Pacheco Y; Devouassoux G
    Rev Mal Respir; 2012 Feb; 29(2):118-27. PubMed ID: 22405107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis.
    Picado C; Mullol J; Roca-Ferrer J
    J Allergy Clin Immunol; 2023 Feb; 151(2):310-313. PubMed ID: 36126795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.
    Choi GS; Kim JH; Shin YS; Ye YM; Kim SH; Park HS
    Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
    Laidlaw TM; Buchheit KM; Cahill KN; Hacker J; Cho L; Cui J; Feng C; Chen CC; Le M; Israel E; Boyce JA
    J Allergy Clin Immunol; 2023 Sep; 152(3):700-710.e3. PubMed ID: 37068712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
    Buchheit KM; Cahill KN; Katz HR; Murphy KC; Feng C; Lee-Sarwar K; Lai J; Bhattacharyya N; Israel E; Boyce JA; Laidlaw TM
    J Allergy Clin Immunol; 2016 May; 137(5):1566-1576.e5. PubMed ID: 26691435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil production of prostaglandin D
    Feng X; Ramsden MK; Negri J; Baker MG; Payne SC; Borish L; Steinke JW
    J Allergy Clin Immunol; 2016 Oct; 138(4):1089-1097.e3. PubMed ID: 27423494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics.
    Adamusiak AM; Stasikowska-Kanicka O; Lewandowska-Polak A; Danilewicz M; Wagrowska-Danilewicz M; Jankowski A; Kowalski ML; Pawliczak R
    Int Arch Allergy Immunol; 2012; 157(4):354-62. PubMed ID: 22123288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.
    Liu T; Laidlaw TM; Katz HR; Boyce JA
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16987-92. PubMed ID: 24085850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular interactions in aspirin-exacerbated respiratory disease.
    Badrani JH; Doherty TA
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):65-70. PubMed ID: 33306487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on recent advances in the management of aspirin exacerbated respiratory disease.
    Palikhe NS; Kim JH; Park HS
    Yonsei Med J; 2009 Dec; 50(6):744-50. PubMed ID: 20046412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis.
    Pérez-Novo CA; Watelet JB; Claeys C; Van Cauwenberge P; Bachert C
    J Allergy Clin Immunol; 2005 Jun; 115(6):1189-96. PubMed ID: 15940133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity.
    Machado-Carvalho L; Roca-Ferrer J; Picado C
    Respir Res; 2014 Aug; 15(1):100. PubMed ID: 25155136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper airways in aspirin-exacerbated respiratory disease.
    Choi JH; Kim JH; Park HS
    Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
    Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
    Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.